Clover Health Investor Class Action Investigation

02.09.2021

Girard Sharp attorneys are investigating potential claims for violation of state and federal law based on reports that Clover Health Investments Corporation made materially misleading claims regarding its business and failed to disclose that it was under investigation by the Department of Justice prior to its transition to a publicly traded company. 

The price of Clover Health stock dropped significantly after the reports were released. 

If you invested in Clover Health Investments, you may have a claim for relief.

Speak with a Girard Sharp investment fraud attorney for a free consultation by calling toll-free at (866) 981-4800 or by filling out the form below: 

Speak to a Lawyer






More Information on Clover Health Investigation 

Clover Health sells Medicare insurance and uses its software platform, known as the Clover Assistant, to provide seniors with PPO and HMO plans. On October 6, 2020, Clover Health announced its plans to merge with SCH—a special-purpose acquisition company—and become a publicly traded company. Shares of Clover Health began trading on NASDAQ on January 8, 2021, under the ticker symbol CLOV. On February 4, 2021, Hidenburg Research released a report that revealed Clover Health’s potential false and misleading statements about its business.  

As a result of this report, Clover Health’s stock price declined more than 12% in one day.

If you invested in Clover Health Investments, you may have a claim. Speak with a Girard Sharp investment fraud attorney about your legal rights by calling toll-free at (866) 981-4800 or by filling out the form above. 

Our Commitment to Excellence 

Girard Sharp has earned national Tier 1 rankings for Mass Tort and Class Action Litigation and has been named to the U.S. News – Best Lawyers “Best Law Firms” list each year since 2013. Read about some of our results. 

We have recovered over a billion dollars for our clients against some of the nation’s largest corporations, such as Raymond James, Peregrine Financial Group, and OppenheimerFunds, in cases arising from securities fraud, false advertising and other unfair business practices.  

For a free consultation about your potential claims, contact one of our investment fraud attorneys at (866) 981-4800 or by filling out the form above.

Main Menu